Scientific Online Resource System

Social Medicine

Improvement of Reimbursement Policies for Medical Products Through Health Technology Assessment

Iliyana Belichenova, Evgeniya Delcheva

Abstract

Reimbursement policies for medical devices in EU and health technology assessment (HTA) are at the heart of this article. Their development is the result of coordination of many institutions - the European Commission, the European Parliament, the government, agencies and their importance is key. The financial instruments in the reimbursement policies for medical devices in the EU are becoming more and more avant-garde, with the key importance of those from donations or crowdfunding, fundraising for patient organizations and others. The authors emphasize the role of public administration in the formation of effective reimbursement policies for medical devices in line with trends and good practices in the field of medical devices and active participation in the processes, together with European institutions and programs. The authors of the article discuss alternative and innovative approaches, budget impact assessment and reimbursement policies for medical devices in Europe and the EU based on HTA.
The authors focus their research on the European experience, the synchronization with European regulations, the harmo-nization of management methods and the role of HTA in the field of management of public funds by institutions and public organizations in Bulgaria.
The authors of the publication examine the experience of international institutes in the field of HTA-experience of Great Britain, Germany, France, given the benchmark they have and the need to educate health professionals, administrators, companies in Bulgaria.

Keywords

reimbursement policies, medical devices, EU, health technology assessment

Full Text


References

Минков К., Финансови инструментии - публично-частни партньорства http://www.aksyst.com:8081/AgoraOpac/ Uploads/KM.pdf

Модели за финансиране на здравеопазването: Възмож- ности за България https://ime.bg/var/images/Healthcare_ Models_Final_IME_1.pdf

Нончев А., Мониторинг и оценка на публични поли- тики и програми, https://library.fes.de/pdf-files/bueros/ sofia/07776.pdf

Регламент (ЕС) 2017/745 на Европйския парламент

Регламент за изпълнението на Норвежкия финансов механизъм 2014–2021 г.- https://www.eeagrants.bg/assets/ resourcedocuments/1572/NFMRegulation_BG.pdf;

Справочник относно финансирането от ЕС-http:// uni-sz.bg/truni11/wp-content/uploads/biblioteka/file/ TUNI10042330.pdf

Устойчив начин за постигане на икономическите и социални цели на ЕС Финансови инструменти-https:// www.fi-compass.eu/sites/default/files/publications/ESIF_A_ sustainable_way_of_achieving_EU_economic_and_social_ objectives_BG.pdf

Финансиране от ЕС на AI което да оптимизира публично финансиране на здравеопазването-https://www.cio.bg/ analizi/2020/06/26/4084034_es_otpravia_pogled_kum_ izkustveniia_intelekt/

Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS, or French Health Products Safety Agency): https://www.ansm.sante.fr/Mediatheque/ Publications/Information-in-English.

AWMSG website at www.wales.nhs.uk/awmsg/.

All Wales Medicines Strategy Group (AWMSG): www. wales.nhs.uk/awmsgThe project “CrowdStream – Crowdfunding to stream innovation” aims at improving the effectiveness of public/private business support http://www. interreg-danube.eu/approved-projects/crowdstream;

Cannon, Christopher M. An Executive’s Guide to Fundraising Operations: Principles, Tools and Trends. John Wiley & Sons, 2011

Commission Nationale d’Evaluation des Dispositifs Médicaux et des Technologies de Santé (CNEDiMTS- https://www.has-sante.fr/jcms/c_419486/fr/commission- nationale-d-evaluation-des-dispositifs-medicaux-et-des- technologies-de-sante

Department of Health: http://www.dh.gov.uk/

European Parliament, Financing for development Post 2015: Improving the contribution of private finance, 2014, at: https://europa.eu/eyd2015/sites/default/files/users/maja. ljubic/expo-deve_et2014433848_en.pdf.

HTA Agency – NICE: http://www.nice.org.uk/

Macarthur. Pharmaceutical Pricing and Reimbursement in the United Kingdom. HEPAC Health Economics in Prevention and Care 2000; 1(1):47–50.

NHS http://www.nhs.uk/Pages/homepage.aspx Tempel, Eugene R. (ed.); Seiler, Timothy L. (ed.); Aldrich, Eva

E. (ed.) and Hank Rosso. Achieving Excellence in Fund Raising. 3rd ed. Jossey-Bass Publishers, 2010.

OECD, The Where of Development Finance: Towards better targeting concessional finance, 2013, available at: http:// www.oecd.org/dac/financing-sustainabledevelopment/ Where%20paper.pdf 29 Action for Global Health, Health Spending in Uganda, April 2010, available at: http:// www.actionforglobalhealth.eu/fileadmin/AfGH_Intranet/ AFGH/Publications/PolicyBriefi ng1_Final1_ LoRes_02. pdf 30 United Nations, Development Initiatives and UK Aid, Improving ODA Allocation for a Post2015 World, available at: http://www.un.org/en/ecosoc/newfunct/pdf15/ un_improving_oda_allocation_for_post2015_world_policy_ briefing.pdf

Powell, William H. and Paul J. Kirpes Raising Money for Mighty Missions: Steps to Success – Doing What

Matters Most: How Charitable, Non-Profit and Faith-Based Organisations Can Raise More Money to Fulfill Their Missions. Powell Publications. 2011.21. Robinson

R, Dixon A. . Health care systems in transition: United Kingdom. Copenhagen, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, 1999. Available at: http://www.euro.who.int/ document/e68283.pdf

UK Medicines Agency: http://www.mhra.gov.uk/

Federal institute for drugs and medical devices- https://www. bfarm.de/EN/Home/home_node.html




DOI: http://dx.doi.org/10.14748/sm.v28i1.7849

Refbacks

Font Size


|